INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 42h ago
House PTR2h ago
SEC 13F2h ago
Robinhood Chain2h ago

Most active filers · 30d

  1. 01Kurtz George0B / 220S220 trades$52.89M
  2. 02SPSaba Capital Management, L.P.66B / 18S · 11 late84 trades$24.31M
  3. 03SJSheena Jonathan0B / 57S57 trades$3.61M
  4. 04ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  5. 05AJAllaire Jeremy0B / 50S50 trades$4.26M
  6. 06Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  7. 07SLSpeiser Michael L0B / 35S35 trades$14.00M
  8. 08RARothblatt Martine A0B / 33S33 trades$5.50M
  9. 09RJRubinstein Julie0B / 32S32 trades$5.48M
  10. 10CECrimmins David Edward0B / 31S31 trades$723K

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLMGNIMAGNITE, INC.Nov 5 – Nov 127 insiders$2.27M
  7. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  8. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M

Form 4 transactions

69,473 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
5
LY
Le Pendeven YvesCFO
FNKOFunko, Inc.
Grant or award
A—
123.8K sh
Mar 17, 2026Mar 19, 2026
Page 1090 of 1737
← PrevNext →
traded Mar 17, 2026
+2d
SEC Form 4

Evidence

5
SR
Sivaram RohanCHIEF FINANCIAL OFFICER
CFLTConfluent, Inc.
Disposition to issuer
D—
212.7K sh
Mar 17, 2026Mar 19, 2026
traded Mar 17, 2026
+2dSEC Form 4

Evidence

5
KJ
Kreps Edward JayDirector, CHIEF EXECUTIVE OFFICER
CFLTConfluent, Inc.
Disposition to issuer
D—
150.0K sh
Mar 17, 2026Mar 19, 2026
traded Mar 17, 2026
+2dSEC Form 4

Evidence

5
CL
Caimi LaraDirector
CFLTConfluent, Inc.
Disposition to issuer
D—
8,302 sh
Mar 17, 2026Mar 19, 2026
traded Mar 17, 2026
+2dSEC Form 4

Evidence

5
SR
Sivaram RohanCHIEF FINANCIAL OFFICER
CFLTConfluent, Inc.
Disposition to issuer
D—
319.3K sh
Mar 17, 2026Mar 19, 2026
traded Mar 17, 2026
+2dSEC Form 4

Evidence

4
SJ
Scaringe Robert JDirector, Chief Executive Officer
RIVNRivian Automotive, Inc. / DE
Open-market sale · 10b5-1 plan
SELL$272K
17.4K sh
Mar 17, 2026Mar 19, 2026
traded Mar 17, 2026
+2dSEC Form 4

Evidence

4
LD
Larson Keith DGeneral Counsel and Secretary
VGVenture Global, Inc.
Option exercise · 10b5-1 plan
M$2.53M
3.21M sh
Mar 19, 2026Mar 19, 2026
traded Mar 19, 2026
+0dSEC Form 4

Evidence

4
TR
Thurman Alex R.SVP & CHIEF FINANCIAL OFFICER
GKOSGLAUKOS Corp
Tax withholding · 10b5-1 plan
F$61K
614 sh
Mar 16, 2026Mar 19, 2026
traded Mar 16, 2026
+3dSEC Form 4

Evidence

4
CR
Chatwani RobertPresident General Mgr, Growth
DOCUDOCUSIGN, INC.
Open-market sale · 10b5-1 plan
SELL$64K
1,395 sh
Mar 18, 2026Mar 19, 2026
traded Mar 18, 2026
+1dSEC Form 4

Evidence

4
CV
Capital V LLC10% Owner
DSPViant Technology Inc.
Option exercise · 10b5-1 plan
M—
37.5K sh
Mar 17, 2026Mar 19, 2026
traded Mar 17, 2026
+2dSEC Form 4

Evidence

4
VT
Vanderhook TimothyDirector, CEO and Chairman, 10% Owner
DSPViant Technology Inc.
Option exercise · 10b5-1 plan
M—
12.5K sh
Mar 17, 2026Mar 19, 2026
traded Mar 17, 2026
+2dSEC Form 4

Evidence

4
VC
Vanderhook ChristopherDirector, Chief Operating Officer, 10% Owner
DSPViant Technology Inc.
Option exercise · 10b5-1 plan
M—
12.5K sh
Mar 17, 2026Mar 19, 2026
traded Mar 17, 2026
+2dSEC Form 4

Evidence

4
CR
Chatwani RobertPresident General Mgr, Growth
DOCUDOCUSIGN, INC.
Open-market sale · 10b5-1 plan
SELL$144K
3,085 sh
Mar 18, 2026Mar 19, 2026
traded Mar 18, 2026
+1dSEC Form 4

Evidence

3
LD
Larson Keith DGeneral Counsel and Secretary
VGVenture Global, Inc.
Option exercise · 10b5-1 plan
M—
1.79M sh
Mar 18, 2026Mar 19, 2026
traded Mar 18, 2026
+1dSEC Form 4

Evidence

2
PJ
Peterson JustinChief Technology Officer
TWTradeweb Markets Inc.
Tax withholding · 10b5-1 plan
F$157K
1,241 sh
Mar 17, 2026Mar 19, 2026
traded Mar 17, 2026
+2dSEC Form 4

Evidence

0
TB
Ticho BarryCHIEF MEDICAL OFFICER
STOKStoke Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
1,365 sh
Mar 19, 2026Mar 19, 2026
traded Mar 19, 2026
+0dSEC Form 4

Evidence

0
TB
Ticho BarryCHIEF MEDICAL OFFICER
STOKStoke Therapeutics, Inc.
Option exercise · 10b5-1 plan
M$2,989
1,365 sh
Mar 19, 2026Mar 19, 2026
traded Mar 19, 2026
+0dSEC Form 4

Evidence

0
BS
Blake SarahSVP, Chief Accounting Officer
VGVenture Global, Inc.
Grant or award · 10b5-1 plan
A—
500.0K sh
Mar 18, 2026Mar 19, 2026
traded Mar 18, 2026
+1dSEC Form 4

Evidence

0
VC
Vanderhook ChristopherDirector, Chief Operating Officer, 10% Owner
DSPViant Technology Inc.
Disposition to issuer · 10b5-1 plan
D—
12.5K sh
Mar 17, 2026Mar 19, 2026
traded Mar 17, 2026
+2dSEC Form 4

Evidence

0
CV
Capital V LLC10% Owner
DSPViant Technology Inc.
Disposition to issuer · 10b5-1 plan
D—
37.5K sh
Mar 17, 2026Mar 19, 2026
traded Mar 17, 2026
+2dSEC Form 4

Evidence

0
VT
Vanderhook TimothyDirector, CEO and Chairman, 10% Owner
DSPViant Technology Inc.
Option exercise · 10b5-1 plan
M—
12.5K sh
Mar 17, 2026Mar 19, 2026
traded Mar 17, 2026
+2dSEC Form 4

Evidence

0
VC
Vanderhook ChristopherDirector, Chief Operating Officer, 10% Owner
DSPViant Technology Inc.
Option exercise · 10b5-1 plan
M—
12.5K sh
Mar 17, 2026Mar 19, 2026
traded Mar 17, 2026
+2dSEC Form 4

Evidence

0
VT
Vanderhook TimothyDirector, CEO and Chairman, 10% Owner
DSPViant Technology Inc.
Disposition to issuer · 10b5-1 plan
D—
12.5K sh
Mar 17, 2026Mar 19, 2026
traded Mar 17, 2026
+2dSEC Form 4

Evidence

0
PJ
Peterson JustinChief Technology Officer
TWTradeweb Markets Inc.
Grant or award · 10b5-1 plan
A—
3 sh
Mar 17, 2026Mar 19, 2026
traded Mar 17, 2026
+2dSEC Form 4

Evidence

0
LD
Larson Keith DGeneral Counsel and Secretary
VGVenture Global, Inc.
Grant or award · 10b5-1 plan
A—
500.0K sh
Mar 18, 2026Mar 19, 2026
traded Mar 18, 2026
+1dSEC Form 4

Evidence

0
CV
Capital V LLC10% Owner
DSPViant Technology Inc.
Option exercise · 10b5-1 plan
M—
37.5K sh
Mar 17, 2026Mar 19, 2026
traded Mar 17, 2026
+2dSEC Form 4

Evidence

0
BS
Blake SarahSVP, Chief Accounting Officer
VGVenture Global, Inc.
Option exercise · 10b5-1 plan
M—
200.0K sh
Mar 19, 2026Mar 19, 2026
traded Mar 19, 2026
+0dSEC Form 4

Evidence

57
FJ
Fry David JamesGroup Head Projects & Studies
NEMNEWMONT Corp /DE/
Open-market sale
SELL$2.05M
18.4K sh
Mar 16, 2026Mar 18, 2026
traded Mar 16, 2026
+2dSEC Form 4

Evidence

50
VR
Velaga S. RamPresident, ISG
AVGOBroadcom Inc.
Open-market sale
SELL$1.56M
4,795 sh
Mar 16, 2026Mar 18, 2026
traded Mar 16, 2026
+2dSEC Form 4

Evidence

50
VR
Velaga S. RamPresident, ISG
AVGOBroadcom Inc.
Open-market sale
SELL$1.35M
4,134 sh
Mar 16, 2026Mar 18, 2026
traded Mar 16, 2026
+2dSEC Form 4

Evidence

50
VR
Velaga S. RamPresident, ISG
AVGOBroadcom Inc.
Open-market sale
SELL$1.16M
3,574 sh
Mar 16, 2026Mar 18, 2026
traded Mar 16, 2026
+2dSEC Form 4

Evidence

50
VR
Velaga S. RamPresident, ISG
AVGOBroadcom Inc.
Open-market sale
SELL$1.98M
6,040 sh
Mar 16, 2026Mar 18, 2026
traded Mar 16, 2026
+2dSEC Form 4

Evidence

50
VR
Velaga S. RamPresident, ISG
AVGOBroadcom Inc.
Open-market sale
SELL$1.33M
4,069 sh
Mar 16, 2026Mar 18, 2026
traded Mar 16, 2026
+2dSEC Form 4

Evidence

47
VR
Velaga S. RamPresident, ISG
AVGOBroadcom Inc.
Open-market sale
SELL$2.05M
6,405 sh
Mar 17, 2026Mar 18, 2026
traded Mar 17, 2026
+1dSEC Form 4

Evidence

47
VR
Velaga S. RamPresident, ISG
AVGOBroadcom Inc.
Open-market sale
SELL$568K
1,758 sh
Mar 16, 2026Mar 18, 2026
traded Mar 16, 2026
+2dSEC Form 4

Evidence

47
VR
Velaga S. RamPresident, ISG
AVGOBroadcom Inc.
Open-market sale
SELL$1.82M
5,632 sh
Mar 17, 2026Mar 18, 2026
traded Mar 17, 2026
+1dSEC Form 4

Evidence

47
VR
Velaga S. RamPresident, ISG
AVGOBroadcom Inc.
Open-market sale
SELL$266K
808 sh
Mar 16, 2026Mar 18, 2026
traded Mar 16, 2026
+2dSEC Form 4

Evidence

44
VR
Velaga S. RamPresident, ISG
AVGOBroadcom Inc.
Open-market sale
SELL$116K
360 sh
Mar 16, 2026Mar 18, 2026
traded Mar 16, 2026
+2dSEC Form 4

Evidence

44
LS
Lederman SethDirector, Chief Executive Officer
TNXPTonix Pharmaceuticals Holding Corp.
Open-market purchase
BUY$223K
15.0K sh
Mar 18, 2026Mar 18, 2026
traded Mar 18, 2026
+0dSEC Form 4

Evidence

43
VR
Velaga S. RamPresident, ISG
AVGOBroadcom Inc.
Open-market sale
SELL$1.75M
5,423 sh
Mar 17, 2026Mar 18, 2026
traded Mar 17, 2026
+1dSEC Form 4

Evidence